BSX
NYSEBoston Scientific Corporation
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 17 recent filings. 13 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Monson Jonathan EVP and CFO | Option exercise | 2.09K | $0.00 | — | 2026-07-01 |
Monson Jonathan EVP and CFO | Tax withholding | 1.01K | $43.06 | $43,490.60 | 2026-07-01 |
Monson Jonathan EVP and CFO | Option exercise | 2.09K | $0.00 | — | 2026-07-01 |
Mahoney Michael F Director, Chairman, President & CEO | Gift | 386.76K | $0.00 | — | 2026-05-28 |
Pegus Cheryl Director | Buy (open market) | 1.77K | $56.49 | $99,987.30 | 2026-05-20 |
LUDWIG EDWARD J Director | Buy (open market) | 3.58K | $56.68 | $202,914.40 | 2026-05-20 |
Habiger David C Director | Buy (open market) | 2.2K | $56.95 | $125,279.22 | 2026-05-19 |
Habiger David C Director | Buy (open market) | 2.25K | $55.92 | $125,818.88 | 2026-05-20 |
Zane Ellen M Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
WICHMANN DAVID S Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 1.77K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 1.14K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 2.66K | $0.00 | — | 2026-05-07 |
Smith Cathy R Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Smith Cathy R Director | Grant / award | 2.21K | $0.00 | — | 2026-05-07 |
Pegus Cheryl Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Pegus Cheryl Director | Grant / award | 1.28K | $0.00 | — | 2026-05-07 |
Source: SEC EDGAR Forms 4/4A (CIK 885725). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$BSX 47 👀
$BSX , the penumbra deal is going to look cheap by the time it closes. 15% YOY revenue growth https://www.penumbrainc.com/penumbra-inc-reports-second-quarter-2026-financial-results/
$FIGS $BSX note to self, should have added more of both these today, pricing constructive.
$BSX green monthly candle
$LKQ 🤩🤩🤩 how'd i miss this drop! In! $bsX $weN $tscO
$BSX overleveraged
$BSX Looks like accumulation but keeps overshooting into positive
$BSX Nice recovery, time avg down and accumulate...
$BSX wow this stock has been flat right at $46 for days… during an earnings week. Incredible
$BSX interesting things: shorts are trying to drop this stock down as usual, but it simply doesn't work anymore. It will be wise to start covering.
$BSX 3 days in a row big drop at open to nearly recover by close. Not sure if that’s bearish or bullish
$BSX weekly and daily MACD are turning green.. there's been buying in this range.. taking some November calls for a swing
Latest news
BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook
Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls
Argus Downgrades Boston Scientific to Hold From Buy
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says
Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says
Leerink Partners Adjusts Boston Scientific Price Target to $60 From $74, Maintains Outperform Rating
Wells Fargo Adjusts Boston Scientific Price Target to $50 From $55, Maintains Equal Weight Rating
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.